conscience
发表于 2025-3-25 07:12:08
The Variations of Metabolic Detoxification Enzymes Lead to Recurrent Miscarriage and Their Diagnosisnation of metabolic enzyme activity may become an important factor in the diagnosis of RM etiology and seeking methods to improve the detoxification ability has a great significance for the treatment of RM.
Conduit
发表于 2025-3-25 10:47:20
http://reply.papertrans.cn/32/3125/312459/312459_22.png
北极熊
发表于 2025-3-25 13:46:10
http://reply.papertrans.cn/32/3125/312459/312459_23.png
OATH
发表于 2025-3-25 18:18:44
http://reply.papertrans.cn/32/3125/312459/312459_24.png
解决
发表于 2025-3-25 22:12:44
Book 2021roductive process is more complex, the reproductive system is more fragile, and is more vulnerable to be damaged. The aim of this book is to review the research progress, to address the challenges, and to stimulate the development in the direction of environment and female reproductive health..
notification
发表于 2025-3-26 00:54:27
http://reply.papertrans.cn/32/3125/312459/312459_26.png
mitten
发表于 2025-3-26 06:40:08
https://doi.org/10.1057/9781137399939f some reproductive diseases occur, these processes will be abnormal, causing infertility problem. In this Chapter, we will describe the female reproductive process and their corresponding reproductive diseases.
vector
发表于 2025-3-26 11:32:22
http://reply.papertrans.cn/32/3125/312459/312459_28.png
追踪
发表于 2025-3-26 14:53:00
https://doi.org/10.1007/978-1-4899-5962-1It is strictly defined as more than 4 months of oligomenorrhea or amenorrhea in a woman <40 years old, associated with at least two follicle-stimulating hormone (FSH) levels >25 U/L in the menopausal range, detected more than 4 weeks apart. It is estimated that POI was affected 1 and 2% of women. Al
anticipate
发表于 2025-3-26 17:18:38
https://doi.org/10.1007/978-1-4614-3275-3rocess that disrupts the finely tuned interactions of hypothalamo–pituitary–ovarian axis can potentially lead to anovulation. The World Health Organization (WHO) has classified anovulatory disorders into three categories: hypothalamic–pituitary failure, hypothalamic–pituitary dysregulation, and ovar